Stock price Bristol-Myers Squibb Company (BMY) today

Bristol-Myers Squibb is a global biopharmaceutical company, a manufacturer of prescription drugs. It also produces biologics in a number of therapeutic areas, including HIV / AIDS, cancer, hepatitis, diabetes, mental disorders, rheumatoid arthritis and many others. It is part of S & P 100 and S & P 500. The company was formed in 1989 as a result of the merger of large pharmaceutical holdings: Bristol-Myers and Squibb.The company is actively engaged in the absorption of other pharmaceutical companies, releasing their developments under its own brand, as well as The company was restructured in 2009 with the aim of transforming Bristol-Myers Squibb into a biopharmaceutical company, followed by the closure of half of its production facilities to reduce costs. In the same year, the company became part of the Fortune 500. At the beginning of 2019, announced the purchase of Celgene for $ 95 billion, which will be the largest transaction in the history of Bristol-Myers Squibb.